Nkarta, Inc. (NKTX) News
Track canonical SquawkNews coverage tagged to NKTX, Nkarta, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 5 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
NKTX - Nkarta to Participate in September Investor Conferences
NKTX - Nkarta to Participate in September Investor Conferences
EQUITY | Sep 10, 2026, 11:00 AM UTC
L
Nkarta selected for ACR Convergence 2026 autoimmune NKX019 presentations
Nkarta said it was selected for three scientific presentations at ACR Convergence 2026, where it will present initial autoimmune clinical data for NKX019.
EQUITY | Sep 08, 2026, 11:07 AM UTC
L
Nkarta to present initial autoimmune clinical data for NKX019 at ACR Convergence 2026
Nkarta plans to present initial autoimmune clinical data for NKX019 at ACR Convergence 2026.
EQUITY | Sep 08, 2026, 11:01 AM UTC
M
Banks Initiate Coverage
Multiple banks initiate coverage on various stocks with different ratings
EQUITY | Jun 23, 2026, 10:55 AM UTC
M
CASY, GEHC, MOH, NKTX Initiated
CASY, GEHC, MOH, and NKTX have been initiated with ratings by CapitalOne, RBC, and TD Cowen
EQUITY | Jun 23, 2026, 09:42 AM UTC